Endpoint methods library
Sensorimotor gating endpoint

Prepulse inhibition

Percent reduction in startle response when a weak prepulse precedes a stronger startling pulse.

Unit
percent inhibition
Readout
Percent reduction of startle amplitude on prepulse-plus-pulse trials versus pulse-alone trials
Assays
Acoustic startle PPI, pharmacology, schizophrenia models, autism models, startle gating screens

Decision summary

Use prepulse inhibition when the experiment asks about sensorimotor gating or modulation of the acoustic startle reflex. The endpoint is strongest when pulse-alone amplitude, prepulse intensities, inter-stimulus intervals, background noise, hearing status, and baseline movement are reported together.

Primary valuePercent reduction of startle amplitude on prepulse-plus-pulse trials versus pulse-alone trials
Common unitsPercent PPI at each prepulse intensity or inter-stimulus interval
Compatible assaysAcoustic startle PPI, pharmacology, schizophrenia models, autism models, startle gating screens
Required boundaryPulse intensity, prepulse intensity, interval, response window, and formula denominator
Do not infer aloneCognition, attention, schizophrenia-like state, hearing acuity, or startle capacity

Measurement notes

Calculate PPI from matched pulse-alone and prepulse-plus-pulse trials. Report each prepulse intensity separately when possible because a single average can hide intensity-dependent gating or baseline startle floor effects.

Interpretation limit

Reduced PPI can support impaired sensorimotor gating, but it can also reflect low pulse-alone amplitude, hearing deficits, high baseline movement, trial noise, prepulse salience, drug-induced sedation, or strain-specific startle profiles.

Data capture

Store animal ID, trial type, pulse intensity, prepulse intensity, inter-stimulus interval, background noise, pulse-alone amplitude, prepulse-plus-pulse amplitude, percent PPI, baseline movement, chamber ID, and exclusion flags.

Confound checks
  • Low or saturated pulse-alone startle amplitude compressing the PPI denominator.
  • Hearing impairment or prepulse intensity below detection threshold.
  • Baseline movement, chamber noise, or sensor gain differences.
  • Trial-order effects, habituation, sensitization, and inter-trial interval variation.
  • Sedation, motor impairment, body weight, sex, strain, or age effects.
Reporting checklist
  • Pulse intensity, prepulse intensities, background noise, inter-stimulus intervals, and response window.
  • Formula used for percent PPI and whether denominator is subject-level or group-level pulse-alone amplitude.
  • Pulse-alone amplitude, baseline movement, no-stimulus trials, and exclusion rules.
  • Trial sequence, habituation period, inter-trial interval, and randomization scheme.
  • Hearing screen, chamber calibration, sensor type, and amplitude units.
  • Whether PPI is reported by intensity, by interval, or as an averaged summary.